drugset / Trial / NCT02329964

Effectiveness of Sugammadex in LMS Surgery

NCT02329964 ↗

Phase 4 Unknown 80 enrolled Korea University Anam Hospital
RandomizedParallel-groupDouble-blindSupportive care

Summary

This study is comparing of rocuronium-sugammadex and succinylcholine during LMS surgery that is characterized by short operation time, required intense paralysis and ambulatory setting, has not been investigated.

Timeline

Start
2015-02
Primary completion
2015-08
Completion
2016-09

Outcome

Met primary endpoint

paper Reversal of profound high-dose rocuronium-induced neuromuscular block (1.2 mg/kg) with 16 mg/kg sugammadex was significantly faster than spontaneous recovery from 1 mg/kg succinylcholine. PMID 19387176 ↗

Drugs

EvaluationDrugModalityDoseRoute
Comparator Neostigmine Other / unclassified 0.2 mg/kg —
Subject Sugammadex Other / unclassified 2 mg/kg —

Indications

No indication recorded.